Stevanato Group S.p.A. (New York Stock Exchange:STVN)
| Market Cap | 5.26B-20.9% |
| Revenue (ttm) | 1.22B+6.7% |
| Net Income | 134.25M-0.2% |
| EPS | 0.48-4.0% |
| Shares Out | 273.01M |
| PE Ratio | 35.75 |
| Forward PE | 26.77 |
| Dividend | $0.06(0.32%) |
| Ex-Dividend Date | Jun 11, 2026 |
| Volume | 69,161 |
| Open | 19.44 |
| Previous Close | 19.44 |
| Day's Range | 19.00 - 19.55 |
| 52-Week Range | 12.89 - 27.99 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 25.58(+32.88%) |
| Earnings Date | Nov 5, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About STVN
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$STVN stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in STVN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by STVN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
STVN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
STVN Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New STVN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to STVN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in STVN
| ETF | Est. Holding Size |
|---|---|
| IBBiShares Biotechnology ETF | $7.47M |
| KOMPState Street SPDR S&P Kensho New Economies Composite ETF | $1.43M |
| BCSMBaron ETF Trust - Baron SMID Cap ETF | $608.01K |
| AIMSAcuitas Small Cap Active ETF | $559.62K |
| SMLVState Street SPDR US Small Cap Low Volatility Index ETF | $367.82K |
| SCAPInfrastructure Capital Small Cap Income ETF | $278.65K |
Estimated from each fund’s disclosed top holdings × AUM
STVN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from STVN’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score